MicroRNA-21 and PDCD4 expression in colorectal cancer.

INTRODUCTION MiRNAs regulate gene expression by binding to target sites and initiating translational repression and/or mRNA degradation. Studies have shown that miR-21 exerts its oncogenic activity by targeting the PDCD4 tumour suppressor 3'-UTR. However, the mechanism of this regulation is poorly understood. In colorectal cancer, loss of PDCD4 has been reported in association with increased tumour aggressiveness and poor prognosis. The purpose of this study was to delineate the interaction between PDCD4 and its oncogenic modulator miR-21 in colorectal cancer. METHODS A cohort of 48 colorectal tumours, 61 normal tissues and 7 polyps were profiled for miR-21 and PDCD4 gene expression. A subset of 48 specimens (31 tumours and 17 normal tissues) were analysed for PDCD4 protein expression by immunohistochemistry. RESULTS A significant inverse relationship between miR-21 and PDCD4 gene expression (p < 0.001) was identified by RT-qPCR. In addition, significant reduction of PDCD4 (p < 0.001) expression and reciprocal upregulation of miR-21 (p = 0.005) in a progressive manner from tumour-polyp-normal mucosae was identified. Analysis of protein expression by IHC revealed loss of PDCD4 staining in tumour tissue. Patients with disease recurrence had higher levels of miR-21. CONCLUSION This study demonstrates the inverse relationship between miR-21 and PDCD4, thus suggesting that miR-21 post-transcriptionally modulates PDCD4 via mRNA degradation. Pharmacological manipulation of the miR-21/PDCD4 axis could represent a novel therapeutic strategy in the treatment of colorectal cancer.

[1]  H. Kizaki,et al.  Cloning of the TIS gene suppressed by topoisomerase inhibitors. , 1998, Gene.

[2]  S. D. Selcuklu,et al.  miR-21 as a key regulator of oncogenic processes. , 2009, Biochemical Society transactions.

[3]  G. Hutvagner,et al.  Principles and effects of microRNA-mediated post-transcriptional gene regulation , 2006, Oncogene.

[4]  R. DuBois,et al.  Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor , 2001, Oncogene.

[5]  D. Bartel,et al.  MicroRNAs Modulate Hematopoietic Lineage Differentiation , 2004, Science.

[6]  M. D'Esposito,et al.  An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation , 2009, Oncogene.

[7]  Iver Petersen,et al.  Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis , 2003, The Journal of pathology.

[8]  Zijie Sun,et al.  Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both β-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells , 2008, Oncogene.

[9]  George A Calin,et al.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. , 2008, JAMA.

[10]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[11]  H. Allgayer,et al.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer , 2008, Oncogene.

[12]  N. Miller,et al.  Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer , 2008, BMC Molecular Biology.

[13]  H. Allgayer,et al.  Loss of programmed cell death 4 expression marks adenoma‐carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer , 2007, Cancer.

[14]  N. Colburn,et al.  Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[15]  H. Allgayer,et al.  Down-regulation of E-cadherin is an essential event in activating β-catenin/Tcf dependent transcription and expression of its target genes in Pdcd4 knock-down cells , 2009, Oncogene.

[16]  K. Klempnauer,et al.  The chicken Pdcd4 gene is regulated by v-Myb , 2001, Oncogene.

[17]  N. Miller,et al.  Identification of endogenous control genes for normalisation of real-time quantitative PCR data in colorectal cancer , 2010, BMC Molecular Biology.

[18]  Y. Pekarsky,et al.  Akt phosphorylates and regulates Pdcd4 tumor suppressor protein. , 2005, Cancer research.

[19]  Shuji Fujita,et al.  Locked Nucleic Acid In situ Hybridization Analysis of miR-21 Expression during Colorectal Cancer Development , 2009, Clinical Cancer Research.

[20]  Wendy Frankel,et al.  MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival , 2008, Journal of Gastrointestinal Surgery.

[21]  K. Klempnauer,et al.  The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA , 2003, Oncogene.

[22]  H. Allgayer Pdcd4, a colon cancer prognostic that is regulated by a microRNA. , 2007, Critical reviews in oncology/hematology.

[23]  N. Colburn,et al.  Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. , 2005, Cancer research.

[24]  N. Colburn,et al.  MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene , 2008, Oncogene.

[25]  N. Colburn,et al.  A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-κB or ODC transactivation , 2001, Oncogene.

[26]  Qiong Shao,et al.  MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. , 2008, RNA.

[27]  E. Lai Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation , 2002, Nature Genetics.

[28]  Michele Pagano,et al.  S6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth , 2006, Science.

[29]  J. Vandesompele,et al.  MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer , 2010, BMC Cancer.

[30]  Shuomin Zhu,et al.  MicroRNA-21 targets tumor suppressor genes in invasion and metastasis , 2008, Cell Research.